Profile of p53 gene mutation and abnormal expression of p53 protein in the two types of esophageal cancer;Profil des mutations du gene p53 et expression anormale de la proteine p53 dans les deux formes de cancer de l'oesophage

Gastroenterologie Clinique et Biologique

Volumn 20, Issue 5, 1996, Pages 430-437

  Muzeau, Françoise ^a   Fléjou, Jean François ^a,b   Potet, François ^a   Belghiti, Jacques ^b   Thomas, Gilles ^c   Hamelin, Richard ^c  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

^c INSTITUT CURIE   (France)

Author keywords

Barrett's adenocarcinoma; Cancer of the esophagus; p53 gene; p53 protein; Squamous cell carcinoma of the esophagus

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DENATURING GRADIENT GEL ELECTROPHORESIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; NUCLEIC ACID BASE SUBSTITUTION; SQUAMOUS CELL CARCINOMA; CANCER STAGING; ELECTROPHORESIS; ENZYME IMMUNOASSAY; ESOPHAGUS TUMOR; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ELECTROPHORESIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029704768     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Daynes NE, Munoz N. Esophagus. In Schottenfield D, Fraumeni J, eds. Cancer Epidemiology and Prevention. Philadelphia : WB Saunders, 1982;596-623.
3. Spechler SJ, Goyal RJ. Barrett's esophagus. N Engl J Med 1986;315:362-71.
4. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
5. Vogelstein B, Fearon ER, Hamilton SR, Kern S, Preisinger A, Leppert M et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
6. Fearon ER, Vogelstein BA. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
7. Soussi T, Caron de Fromontel C, May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 1990;5:945-52.
8. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
9. Kuerbitz SJ, Plunkett BS, Walsh WW, Kastan MB. Wild-type p53 is a cell cyle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 1992;89:7491-5.
10. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992;70: 937-48.
11. Lane DP. p53, guardian of the genome. Nature 1992;358:15-6.
12. Tominaga O, Hamelin R, Remvikos Y, Salmon RJ, Thomas G. p53 from basic research to clinical applications. Crit Rev Oncogene 1992;3:257-82.
13. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993;329:1318-27.
14. Reihsaus E, Kohler M, Kraiss S, Oren M, Monternarh M. Regulation of the level of the oncoprotein p53, in non-transformed and transformed cells. Oncogene 1990;5:137-45.
15. Banks L, Matlasshewski G, Crawford L. Isolation of human-p53 specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986;159:529-34.
16. Mason DY, Summons RE. The labeled antigen method of immunoperoxidase staining. J Histochem Cytochem 1979;27: 832-40.
17. Fischer SG, Lerman LS. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 1983;80:1579-83.
18. Hamelin R, Jego N, Laurent-Puig P, Vidaud M, Thomas G. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene 1993;8: 2213-20.
19. Hamelin R, Fléjou JF, Muzeau F, Potet F, Laurent-Puig P, Fékété F et al. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 1994;107:1012-8.
20. Imazeki F, Omata M, Nose H, Ohto M, Isono K. p53 gene mutations in gastric and esophageal cancers. Gastroenterology 1992;103:892-6.
21. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
22. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Klöppel G et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991; 64:1076-82.
23. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991;350:427-8.
24. Volant A, Nousbaum JB, Giroux MA, Roué-Quintin I, Metges JP, Férec C et al. p53 accumulation in oesophageal squamous cell carcinomas and precancerous lesions. J Clin Pathol 1995;48:531-4.
25. Ramel S, Reid BJ, Sanchez CA, Blount PL, Levine DS, Neshat K et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 1992;102:1220-8.
26. Younes M, Lebovitz RM, Lechago LV, Lechago J. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology 1993;105:1637-42.
27. Fléjou JF, Paraf F, Potet F, Fékété F. Le cancer superficiel sur endobrachyoesophage. Gastroenterol Clin Biol 1994;18: D59-D62.
28. Hollstein MC, Peri L, Mandart AM, Welsh JA, Montesano R, Metcalf RA et al. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991;51:4102-6.
29. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM et al. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992;52:6092-7.
30. Audrézet MP, Robaszkiewicz M, Mercier B, Nousbaum JB, Bail JP, Hardy E et al. TP53 gene mutation profile in esophageal squamous cell carcinomas. Cancer Res 1993;53:5745-9.
31. Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW et al. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 1993;53:846-50.
32. Moyret C, Theillet C, Laurent-Puig P, Molés JP, Thomas G, Hamelin R. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 1994;9:1739-43.
33. Vogelstein B, Kinsler W. p53 function and disfunction. Cell 1992;70:523-6.
34. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 1991;51:4495-9.
35. Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G et al. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994;106:1589-95.
36. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Russell SEH. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res 1995;55:3406-11.
37. Tamura G, Maesawa C, Suzuki Y, Satodate R, Ishida K, Saito K. p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Jpn J Cancer Res 1992;83:559-62.
38. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T et al. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 1992;52:734-6.
39. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-51.
40. Nguyen T, Brunson D, Crespi CL, Pennan BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992; 89:3030-4.